Guidelines for analytical method development and validation of biotechnological synthesis of drugs. Production of a hydroxyprogesterone as model.
In connection with biotechnological synthesis of pharmaceutical drugs, validated methods for quantification of both product and substrate at different time intervals are essential for proper calculation of rate coefficients. In this field, there still exist no guidelines for analytical validation, unlike the situation in the bioanalytical field. Therefore, in this study the detailed guidelines by FDA for bioanalytical method validation were applied to a typical biotechnological process; the enzymatic synthesis of 9alpha-hydroxyprogesterone in E. coli using progesterone as substrate. The process liquid was extracted and analyzed using an HPLC-DAD system. The quality control (QC) samples of the product demonstrated excellent precision (C.V.<1.5%) and accuracy between 99.3 and 107%. The study showed that the recommendations and the validation terms for bioanalytical methods can be used also for biotechnological production, but with some important exceptions. The tolerances (C.V. values) of the validation terms should be much narrower; the internal standard (I.S.) must be present in the process liquid before the start of the process and must be much different in structure from the substrate (so as not to participate in the biotechnological process). In addition, the selectivity must be checked very frequently during the process due to the changes in the blank process liquid with time.
Lindholm
Johan
J
Center for Surface Biotechnology, BMC Box 577, Uppsala University, SE-751 23 Uppsala, Sweden.
Johansson
Monika
M
Fornstedt
Torgny
T
D001709:Biotechnology; D002138:Calibration; D002851:Chromatography, High Pressure Liquid; D005285:Fermentation; D006908:Hydroxyprogesterones / Q000032:analysis* / Q000138:chemical synthesis*; D008956:Models, Chemical; D012680:Sensitivity and Specificity
D006908:Hydroxyprogesterones